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Introduction

Deposition of fibronectin (FN) into extracellular matrix (ECM) is a dynamic
process that is tightly regulated and controlled despite the presence of high concentrations of FN in plasma (200-600 µg/ml, 440-1320 nM) and other body fluids (1, 2) . FN is a disulfide-linked dimer of 230-250 kDa subunits. Each subunit is comprised mostly of 3 types of repeating modules-12 type I modules, 2 type II modules, and 15 to 17 type III modules depending on splicing-and a variable region (V0, V64, V89, V95, and V120) that is not homologous to other parts of FN. There are two general types of FN: plasma FN (pFN), which is secreted by hepatocytes; and cellular FN (cFN), which is expressed and secreted by fibroblasts and other cell types. There are several structural differences between pFN and cFN. Two type III modules (EDa and EDb) are missing completely in pFN, but variably present in cFN. The V region is also completely missing in one of its subunits in pFN, but present in both subunits of cFN (1, 3) . Cell adhesion to immobilized FN by α5β1 integrin is mediated by the RGD sequence in the 10 th type III module (III 10 ) (4-6).
FN matrix assembly is a cell-dependent process that takes place at specialized sites on cell surfaces (7) . The N-terminal 70-kDa region of FN binds to these sites with high affinity in a reversible and saturable manner (8, 9) . Subsequent homophilic interactions among bound FNs are thought to promote polymerization of FN molecules into insoluble matrix (10) (11) (12) (13) (14) . give β1-expressing β1 A GD25 cells (19) or β1 A GD10 cells. β1 A β3 GD10 cells were generated by transfection of GD10 cells by a β1 A /β3 chimeric construct in which the cytoplasmic domain of β1 A was replaced with the cytoplasmic domain of β3 (28) . GFPexpressing FN-null cells were generated by transfection of GFP followed by selection of a stable population with puromycin. A plasmid encoding GFP (pEGFP-N1, CLONTECH Fig 1A) .
Previously, β1-null GD25 cells were shown to be also defective in initial assembly of pFN when cultured on VN, and co-coating experiments indicated that the defective assembly is due to a suppressive effect of VN (35) . Similar co-coating experiments with FN-null cells indicated that VN is also suppressive for FN-null cells.
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Thus, a co-coat with 6-9 µg/ml pFN overcame the negative effects of a coat of 2 µg/ml VN on FN-null cells ( Fig. 2A) as effectively as it did with control β1-null cells (results not shown). Coating with an increasing amount of LN also overcame the suppressive effects of VN, and an increasing amount of VN overcame the facilitating effect of LN ( Fig. 2A) . Interestingly, whereas a coat of 5 µg/ml LN poorly supported adhesion and assembly of pFN by FN-null cells, addition of an intermediate coat of 3 µg/ml VN enhanced the facilitating effect of LN ( Fig. 2A) . A coat with 10 µg/ml III 7-10 did not overcome the negative effect of 2 µg/ml VN and did not suppress the facilitating effect of 2 µg/ml FN ( were less spread than cFN-expressing cells (Fig. 3A) . When cFN-expressing cells were the dominating population, deposited cFN fibrils were observed throughout the culture (Fig. 3A) . In contrast, preferential assembly of endogenous cFN was observed on cFNexpressing cells when GFP-expressing FN-null cells were the dominating population (Fig. 3A) . Fibrils of cFN were also found on GFP-expressing FN-null cells adjacent to cFN-expressing cells (arrowhead in Fig. 3A ). There was no assembly of cFN in a mixed culture of FN-null cells and GFP-expressing FN-null cells (results not shown).
We then explored whether exogenous pFN is locally deposited on cFN-expressing cells in the co-cultures of cFN-expressing cells and cytoplasmic GFP-expressing FN-null cells mixed at 1:20. The mix in DMEM containing 0.2% BSA and 9 µg/ml Rx-pFN were cultured for 18 hours at 37 °C on pFN-, LN-, or VN-coated cover slips (pFN+Rx-pFN, LN+Rx-pFN or VN+Rx-pFN, respectively). Preferential assembly of exogenous pFN was observed on and around the cFN-expressing cells when adherent to VN (Fig. 3B) . In mixed cultures on pFN or LN, exogenous pFN was assembled by both cFN-expressing cells and GFP-expressing FN-null cells (Fig. 3B) .
To corroborate the finding that endogenous cFN expression is associated with preferential deposition of exogenous pFN when cells are cultured on VN and test the need for EDa, GFP-tagged cFN splice variants, GFP-FN(EDa+) or GFP-FN(EDa-), were transiently expressed in FN-null cells (Fig. 4) . The mix of rare transiently-transfected cells expressing GFP-FN and non-transfected FN-null cells in DMEM containing 0.2 % BSA and 9 µg/ml Rx-pFN were cultured at 37 °C for 18 hours on VN-coated cover slips.
The EDa-specific monoclonal antibody IST-9 and Alexa Fluor R 350 goat anti-mouse
IgG were used to detect GFP-FN(EDa+). Both GFP-FNs were detected in fibrillar patterns. The GFP signal colocalized with IST-9 around cells expressing GFP- Fig. 4 ). FNnull cells cultured for 18 hours in DMEM containing 0.2 % BSA and 9 µg/ml Rx-pFN on VN-coated coverslips poorly assembled Rx-pFN (Fig. 4C ).
FN(EDa+). Rx-pFN was found around cells expressing either GFP-FN(EDa+) or GFP-FN(EDa-) but did not always co-localize with fibrils of GFP-FN (arrows in
The results with endogenously synthesized GFP-FNs indicated that it is the location of synthesis rather than the presence of the alternatively spliced EDa that allows cFN-expressing cells to overcome the suppressive effect of adhesions to VN. To test this conclusion, serum-free culture medium collected after 24-hour incubation of AH1F human dermal fibroblast or insect cell medium that was conditioned with recombinant His-tagged human FNs with or without EDa was incubated with FN-null cells cultured on VN-or LN-coated cover slips. Deposited FN was detected with anti-FN polyclonal rabbit antibody (Fig. 5) . The final concentrations of cFN in AH1F cell medium or EDa+ or EDa-FNs in insect cell media were similar, about 2 µg/ml (results not shown). FN-null cells assembled all these sources of FN equally poorly when the cells were on VN-coated surface and equally well when the cells were on LN-coated surface (Fig. 5) .
Endogenously synthesized cFN interacts more efficiently with β1 integrins than β3
integrins when cells are adherent to VN.
As described above, β1-null GD25 cells, which express endogenous cFN (35), and GFP-expressing FN-null cells, which express α5 and β1 integrin (Fig. 1B) , are both defective in assembly of pFN when cultured on VN as homogenous cultures. To test whether the cells complement one another, the cells were cultured as a mix. Deposited endogenous cFN was detected with anti-FN rabbit polyclonal antibody and Rhodamine Red TM -X conjugated donkey anti-rabbit antibody (Fig. 6A) . Rhodamine red was present diffusely on the surface of β1-null GD25 cells (arrow in Fig. 6A ). Long and thick fibrils of endogenous cFN were preferentially deposited on the neighboring GFP-expressing FN-null cells as compared to the β1-null GD25 cells (arrowhead in Fig. 6A ). To visualize deposition of exogenous pFN, 9 µg/ml Rx-pFN was added to culture medium ( The negative effect of VN on assembly of exogenous pFN by β1-null GD25 cells was overcome by a coat of 6-9 µg/ml pFN (35) , suggesting that ligation of β3 integrins via adhesion to FN rather than VN not only does not generate a suppressive effect but has a positive effect. In other words, β1 integrin-specific signaling is not necessary to overcome the negative effect of VN. In order to explain the observation that expression of functional β1 integrin in cFN-secteting GD25 cells releases the suppressive effect of VN (35), however, one must hypothesize that β1 integrin interacts with endogenous cFN more efficiently than β3 integrin when cells are adherent to VN.
We tested this hypothesis with β1-null GD10, β1 A GD10 cells expressing wild type β1 A , and β1 A β3GD10 cells expressing a chimeric β1 subunit with the extracellular domain of β1 and the cytoplasmic domain of β3. Cells were incubated for 4 hours ( 
